Clinical Trial Update: Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and preliminary efficacy of Pumitamig (BNT327) in combination with chemotherapy for first-line or second-line non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pumitamig

Snippet

Sponsor: BioNTech SE | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING